SR‐B1 knockdown improved the immune microenvironment and intestinal microbiota by controlling the tumor‐associated macrophage, mononuclear myeloid‐derived suppressor cells, granulocytic myeloid‐derived suppressor cells, and programmed cell death‐ligand 1 levels. The gene discussed is SCARB1; the disease is neoplasm.